Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19676102rdf:typepubmed:Citationlld:pubmed
pubmed-article:19676102lifeskim:mentionsumls-concept:C0752121lld:lifeskim
pubmed-article:19676102lifeskim:mentionsumls-concept:C0205341lld:lifeskim
pubmed-article:19676102lifeskim:mentionsumls-concept:C0439659lld:lifeskim
pubmed-article:19676102lifeskim:mentionsumls-concept:C0205214lld:lifeskim
pubmed-article:19676102lifeskim:mentionsumls-concept:C0443239lld:lifeskim
pubmed-article:19676102pubmed:issue2lld:pubmed
pubmed-article:19676102pubmed:dateCreated2010-2-26lld:pubmed
pubmed-article:19676102pubmed:abstractTextThe spinocerebellar ataxia type 2 (SCA2) is an autosomal dominant neurodegenerative disease characterized by gait and limb ataxia. This disease is caused by the expansion of a (CAG)(n) located in the ATXN2, that encodes a polyglutamine tract of more than 34 repeats. Lately, alleles with 32-33 CAGs have been associated to late-onset disease cases. Repeat interruptions by CAA triplets are common in normal alleles, while expanded alleles usually contain a pure repeat tract. To investigate the mutational origin and the instability associated to the ATXN2 repeat, we performed an extensive haplotype study and sequencing of the CAG/CAA repeat, in a cohort of families of different geographic origins and phenotypes. Our results showed (1) CAA interruptions also in expanded ATXN2 alleles; (2) that pathological CAA interrupted alleles shared an ancestral haplotype with pure expanded alleles; and (3) higher genetic diversity in European SCA2 families, suggesting an older European ancestry of SCA2. In conclusion, we found instability towards expansion in interrupted ATXN2 alleles and a shared ancestral ATXN2 haplotype for pure and interrupted expanded alleles; this finding has strong implications in mutation diagnosis and counseling. Our results indicate that interrupted alleles, below the pathological threshold, may be a reservoir of mutable alleles, prone to expansion in subsequent generations, leading to full disease mutation.lld:pubmed
pubmed-article:19676102pubmed:languageenglld:pubmed
pubmed-article:19676102pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19676102pubmed:citationSubsetIMlld:pubmed
pubmed-article:19676102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19676102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19676102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19676102pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19676102pubmed:statusMEDLINElld:pubmed
pubmed-article:19676102pubmed:monthMarlld:pubmed
pubmed-article:19676102pubmed:issn1552-485Xlld:pubmed
pubmed-article:19676102pubmed:authorpubmed-author:SequeirosJorg...lld:pubmed
pubmed-article:19676102pubmed:authorpubmed-author:MartinsSandra...lld:pubmed
pubmed-article:19676102pubmed:authorpubmed-author:AlonsoIsabelIlld:pubmed
pubmed-article:19676102pubmed:authorpubmed-author:SilveiraIsabe...lld:pubmed
pubmed-article:19676102pubmed:authorpubmed-author:CoutinhoPaula...lld:pubmed
pubmed-article:19676102pubmed:authorpubmed-author:JardimLaura...lld:pubmed
pubmed-article:19676102pubmed:authorpubmed-author:Saraiva-Perei...lld:pubmed
pubmed-article:19676102pubmed:authorpubmed-author:RamosEliana...lld:pubmed
pubmed-article:19676102pubmed:authorpubmed-author:EmmelVanessa...lld:pubmed
pubmed-article:19676102pubmed:copyrightInfo(c) 2009 Wiley-Liss, Inc.lld:pubmed
pubmed-article:19676102pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19676102pubmed:day5lld:pubmed
pubmed-article:19676102pubmed:volume153Blld:pubmed
pubmed-article:19676102pubmed:ownerNLMlld:pubmed
pubmed-article:19676102pubmed:authorsCompleteYlld:pubmed
pubmed-article:19676102pubmed:pagination524-31lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:meshHeadingpubmed-meshheading:19676102...lld:pubmed
pubmed-article:19676102pubmed:year2010lld:pubmed
pubmed-article:19676102pubmed:articleTitleCommon origin of pure and interrupted repeat expansions in spinocerebellar ataxia type 2 (SCA2).lld:pubmed
pubmed-article:19676102pubmed:affiliationUnIGENe, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.lld:pubmed
pubmed-article:19676102pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19676102pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:6311entrezgene:pubmedpubmed-article:19676102lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:19676102lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19676102lld:pubmed